SecBot SecBot
SECBOTREPLAY Home › Report › AXSM

AXSM · CEO Herriot Tabuteau filed a Form 144 to sell 49,666 common shares…

Axsome Therapeutics, Inc. · 144 filed Jul 1, 2026 at 17:35 ET

At the news

NEUTRALIMPACT 4/10

144 filed Jul 1, 2026 at 17:35 ET

CEO Herriot Tabuteau filed a Form 144 to sell 49,666 common shares (approx. $11.9M) under a Rule 10b5-1 plan adopted on 3/10/2026. The sale is pre-arranged and part of a planned diversification, reducing concern of opportunistic insider selling.

  • CEO Herriot Tabuteau intends to sell 49,666 shares of common stock (~$11.95M).
  • Sale is under a 10b5-1 trading plan adopted on 3/10/2026.
  • Shares acquired as compensation (stock options) on 3/15/2017.
  • Recent insider selling (30d): 6 sells totaling $20.3M.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access